STOCK TITAN
  1. Home
  2. BHICD

BioScience Health Innovations (BHICD) Stock Price, News & Analysis

BHICD OTC
Published by Stock Titan Data refreshed

What Changed

Company Description

For FY2025, BioScience Health Innovations reported revenue of $5.7M with net income of $642K and diluted earnings per share of $0.06. The company operates at a net profit margin of 11.3%.

This page collects what Stock Titan holds for BHICD, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
-
-
Last updated:
-
Performance 1 year
-
Market Cap
-
Shares outstanding

BHICD Metrics & Rankings

Revenue
$5.7M
#3,412
Piotroski F-Score
5/9
#1,695

Latest News

View All

No recent news available for BHICD.

SEC Filings

View All

[10-Q] BioScience Health Innovations (BHIC) swings to Q1 2026 loss as revenue falls

[8-K] Bioscience Health Innovations (BHIC) CTO Daniel Schmidt joins board after director exit

[10-K] BioScience Health Innovations (OTC: BHIC) triples revenue and boosts profit on MODS Max platform

[10-Q] BHIC posts $4.12M YTD revenue and positive cash flow; control weaknesses flagged

[8-K] BHIC 1-for-4 reverse split approved by board and majority holders

BioScience Health Innovations has filed 5 recent SEC filings, including 2 Form 10-Q, 2 Form 8-K, 1 Form 10-K. The most recent filing was submitted on May 11, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BHICD SEC filings →

Financial Highlights

View Full Financials

BioScience Health Innovations generated $5.7M in revenue in FY2025, retaining a 57.0% gross margin, operating income reached $719K (12.6% operating margin), and net income was $642K, reflecting a 11.3% net profit margin. Diluted earnings per share stood at $0.06. The company generated $172K in operating cash flow.

$5.7M
Revenue (FY2025)
$642K
Net Income (FY2025)
$0.06
Diluted EPS (FY2025)
$172K
Operating Cash Flow
11.3%
Net Profit Margin
12.6%
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

Frequently Asked Questions

What is the revenue of BioScience Health Innovations (BHICD) stock?

The FY2025 revenue of BioScience Health Innovations (BHICD) is $5.7M, from its most recent completed fiscal year.

What is the net income of BioScience Health Innovations (BHICD)?

The FY2025 net income of BioScience Health Innovations (BHICD) is $642K, from its most recent completed fiscal year.

What is the earnings per share (EPS) of BioScience Health Innovations (BHICD)?

The diluted earnings per share (EPS) of BioScience Health Innovations (BHICD) is $0.06 for FY2025, its most recent completed fiscal year. Learn more about EPS .

What is the operating cash flow of BioScience Health Innovations (BHICD)?

The operating cash flow of BioScience Health Innovations (BHICD) is $172K. Learn about cash flow.

What is the profit margin of BioScience Health Innovations (BHICD)?

The net profit margin of BioScience Health Innovations (BHICD) is 11.3%. Learn about profit margins.

What is the operating margin of BioScience Health Innovations (BHICD)?

The operating profit margin of BioScience Health Innovations (BHICD) is 12.6%. Learn about operating margins.

What is the gross margin of BioScience Health Innovations (BHICD)?

The gross profit margin of BioScience Health Innovations (BHICD) is 57.0%. Learn about gross margins.

What is the gross profit of BioScience Health Innovations (BHICD)?

The gross profit of BioScience Health Innovations (BHICD) is $3.2M for FY2025, its most recent completed fiscal year.

What is the operating income of BioScience Health Innovations (BHICD)?

The operating income of BioScience Health Innovations (BHICD) is $719K. Learn about operating income.